KYTHERA Biopharmaceuticals Raises $37.4M

Los Angeles-based KYTHERA Biopharmaceuticals, a developer of aesthetic medicine products, said today that it has raised $37.4M in a series D funding round. The round included new investors Foley Ventures and Latham and Watkins, and also included prior investors Versant Ventures, ARCH Venture Partners, Prospect Venture Partners, JAFCO, Partner Funds management (PFM), INVUS Financial Advisors, BBT Capital Management/Apothecary Capital, and Altitude Life Science Ventures. Kythera said the new investment brings its total raised to more than $108M. The company's lead product is being targeted at removing under the chin fat in patients. More information »